Therapex
- Biotech or pharma, therapeutic R&D
Therapex is a clinical-stage biotech company based in South Korea developing TRX-221, a treatment for EGFR mutated non-small cell lung cancer (NSCLC) currently in Phase 1 development
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}